MCM
TEVA icon

Melvin Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Melvin Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,420,000
Closed -$30.7M – 118
2020
Q1 		$30.7M Sell
3,420,000
-5,980,000
-64% -$61.3M 0.24% 57
2019
Q4 		$92.1M Sell
9,400,000
-2,990,000
-24% -$26.7M 0.76% 47
2019
Q3 		$85.2M Buy
12,390,000
+8,040,000
+185% +$61.6M 0.69% 42
2019
Q2 		$40.2M Buy
+4,350,000
New +$52.5M 0.41% 58
2017
Q3 		– Sell
-1,814,000
Closed -$60.3M – 115
2017
Q2 		$60.3M Buy
+1,814,000
New +$56.1M 0.79% 38

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return